AROCELL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.441 SEK | +2.56% |
|
+9.70% | +0.92% |
| 05-03 | AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.35M | - | |||||
| 58.06B | - | |||||
| 40.53B | ||||||
| 38.99B | ||||||
| 26.7B | ||||||
| 26.56B |
- Stock Market
- Equities
- AROC Stock
- Charts AroCell AB
- Sector Chart
